October 2021

Two decades after scientists first released the draft sequence of the human genome, an international team of genetics research announced that they had successfully mapped 100% of the human genome – identifying more than 100 new genes and millions of genetic variations between humans, some of which could play a role in disease.

While this discovery may be ground-breaking for the genomics sector, switching to a full model of the human genome could prove to be a challenge for many clinical labs, which will have to adjust to this new map of human physiology. To find out more, we speak to genomics experts to find out what clinical labs can do to keep up with this research.

Also in the next issue of Medical Technology, we take a trip to Africa to examine the continents potential as a clinical trial powerhouse. Despite being home to some of the world’s most diverse and densely populated nations, Africa currently contributes to less than 2% of the total number of clinical trials. Could more be done to utilise these seemingly ideal research conditions?

EDITORIAL

Editor | Eloise McLennan
Writers | Chloe Kent, Abi Millar
Magazine Designer | Tyrrell Lowe

Graphic Designers | Anett Arc, Ashley McPherson, Noemi Balint, Maria Gimenez, Filipe Costa, Martina Labaiova, Will Ingham, Dimeji Akinkuolie

Lead Designer | John Hammond
Publisher |Susanne Hauner

Digital Publishing Director | Duncan West

Advertising

Sales Manager | Nimai Amin

+44 (0) 207 936 6453

medical Technology is powered by h5mag

read past issues of medical technologyHERE

Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.

Go to article: Home | Can regulators keep up with AI?Go to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Watlow Company InsightGo to article: WatlowGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: FusetecGo to article: Tricor SystemsGo to article: mdi ConsultantsGo to article: AccumoldGo to article: CommentGo to article: Face masks detecting SARS-CoV-2 are newest weapon to control the pandemicGo to article: Regenerative medicine to drive cartilage repair market to $2bn by 2030Go to article: Covid-19 misinformation circulating on social media can be harmGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: In DepthGo to article: When opposites attract: the problematic pull of pacemakersGo to article: Can regulators keep up with AI in healthcare?Go to article: Elizabeth Holmes on trial: the case against the Theranos founderGo to article: Will there ever be a test for chronic fatigue syndrome?Go to article: Inside the UK’s PCR price problemGo to article: Simulating the Covid-19 vaccine rolloutGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: TS Quality & EngineeringGo to article: SemecsGo to article: In DataGo to article: Data: medical industryGo to article: The medical industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: GeeplusGo to article: Smiths InterconnectGo to article: EventsGo to article: Next Issue